These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 1353535)
1. Site specific screening for point mutations in ornithine transcarbamylase deficiency. Feldmann D; Rozet JM; Pelet A; Hentzen D; Briand P; Hubert P; Largilliere C; Rabier D; Farriaux JP; Munnich A J Med Genet; 1992 Jul; 29(7):471-5. PubMed ID: 1353535 [TBL] [Abstract][Full Text] [Related]
2. Identification of a cytogenetic deletion and of four novel mutations (Q69X, I172F, G188V, G197R) affecting the gene for ornithine transcarbamylase (OTC) in Spanish patients with OTC deficiency. Climent C; García-Pérez MA; Sanjurjo P; Ruiz-Sanz JI; Vilaseca MA; Pineda M; Campistol J; Rubio V Hum Mutat; 1999 Oct; 14(4):352-3. PubMed ID: 10502831 [TBL] [Abstract][Full Text] [Related]
3. Fatal hyperammonemia resulting from a C-to-T mutation at a MspI site of the ornithine transcarbamylase gene. Hentzen D; Pelet A; Feldman D; Rabier D; Berthelot J; Munnich A Hum Genet; 1991 Dec; 88(2):153-6. PubMed ID: 1721894 [TBL] [Abstract][Full Text] [Related]
4. Identification of seven novel missense mutations, two splice-site mutations, two microdeletions and a polymorphic amino acid substitution in the gene for ornithine transcarbamylase (OTC) in patients with OTC deficiency. Climent C; Rubio V Hum Mutat; 2002 Feb; 19(2):185-6. PubMed ID: 11793483 [TBL] [Abstract][Full Text] [Related]
5. Four newly identified ornithine transcarbamylase (OTC) mutations (D126G, R129H, I172M and W332X) in Japanese male patients with early-onset OTC deficiency. Matsuura T; Hoshide R; Kiwaki K; Komaki S; Koike E; Endo F; Oyanagi K; Suzuki Y; Kato I; Ishikawa K Hum Mutat; 1994; 3(4):402-6. PubMed ID: 8081398 [No Abstract] [Full Text] [Related]
6. [A new family with mutation of the structural gene of human ornithine carbamoyltransferase]. Stoll C; Bieth R; Dreyfus J; Flori E; Lutz P; Levy JM Arch Fr Pediatr; 1978 May; 35(5):512-8. PubMed ID: 678030 [TBL] [Abstract][Full Text] [Related]
7. Seven new mutations in the human ornithine transcarbamylase gene. Tuchman M; Plante RJ; McCann MT; Qureshi AA Hum Mutat; 1994; 4(1):57-60. PubMed ID: 7951259 [No Abstract] [Full Text] [Related]
8. Six new mutations in the ornithine transcarbamylase gene detected by single-strand conformational polymorphism. Tuchman M; Holzknecht RA; Gueron AB; Berry SA; Tsai MY Pediatr Res; 1992 Nov; 32(5):600-4. PubMed ID: 1480464 [TBL] [Abstract][Full Text] [Related]
9. Mutations and polymorphisms in the human ornithine transcarbamylase gene. Tuchman M Hum Mutat; 1993; 2(3):174-8. PubMed ID: 8364586 [TBL] [Abstract][Full Text] [Related]
10. Mutation analysis of the ornithine transcarbamylase (OTC) gene in five Japanese OTC deficiency patients revealed two known and three novel mutations including a deep intronic mutation. Ogino W; Takeshima Y; Nishiyama A; Okizuka Y; Yagi M; Tsuneishi S; Saiki K; Kugo M; Matsuo M Kobe J Med Sci; 2007; 53(5):229-40. PubMed ID: 18204299 [TBL] [Abstract][Full Text] [Related]
11. The ornithine transcarbamylase (OTC) gene: mutations in 50 Japanese families with OTC deficiency. Matsuda I; Tanase S Am J Med Genet; 1997 Sep; 71(4):378-83. PubMed ID: 9286441 [TBL] [Abstract][Full Text] [Related]
13. Mutations and polymorphisms in the human ornithine transcarbamylase (OTC) gene. Yamaguchi S; Brailey LL; Morizono H; Bale AE; Tuchman M Hum Mutat; 2006 Jul; 27(7):626-32. PubMed ID: 16786505 [TBL] [Abstract][Full Text] [Related]
14. Clinical and biochemical heterogeneity in females of a large pedigree with ornithine transcarbamylase deficiency due to the R141Q mutation. Ahrens MJ; Berry SA; Whitley CB; Markowitz DJ; Plante RJ; Tuchman M Am J Med Genet; 1996 Dec; 66(3):311-5. PubMed ID: 8985493 [TBL] [Abstract][Full Text] [Related]
15. Prenatal monitoring in a family at high risk for ornithine transcarbamylase (OTC) deficiency: a new mutation of an A-to-C transversion in position +4 of intron 1 of the OTC gene that is likely to abolish enzyme activity. Hoshide R; Matsuura T; Sagara Y; Kubo T; Shimadzu M; Endo F; Matsuda I Am J Med Genet; 1996 Aug; 64(3):459-64. PubMed ID: 8862622 [TBL] [Abstract][Full Text] [Related]
16. Characterization of point mutations in the same arginine codon in three unrelated patients with ornithine transcarbamylase deficiency. Maddalena A; Spence JE; O'Brien WE; Nussbaum RL J Clin Invest; 1988 Oct; 82(4):1353-8. PubMed ID: 3170748 [TBL] [Abstract][Full Text] [Related]
17. The phenotype of ostensibly healthy women who are carriers for ornithine transcarbamylase deficiency. Maestri NE; Lord C; Glynn M; Bale A; Brusilow SW Medicine (Baltimore); 1998 Nov; 77(6):389-97. PubMed ID: 9854602 [TBL] [Abstract][Full Text] [Related]
18. Single-strand conformational polymorphism and direct sequencing applied to carrier testing in families with ornithine transcarbamylase deficiency. Tsai MY; Holzknecht RA; Tuchman M Hum Genet; 1993 May; 91(4):321-5. PubMed ID: 8099056 [TBL] [Abstract][Full Text] [Related]
19. [Ornithine transcarbamylase deficiency]. Hata A Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):500-4. PubMed ID: 2908395 [No Abstract] [Full Text] [Related]
20. Proportions of spontaneous mutations in males and females with ornithine transcarbamylase deficiency. Tuchman M; Matsuda I; Munnich A; Malcolm S; Strautnieks S; Briede T Am J Med Genet; 1995 Jan; 55(1):67-70. PubMed ID: 7702100 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]